Cost-effectiveness of HPV vaccination in the Netherlands
Wednesday, July 1, 2009 - 17:21
in Health & Medicine
Even under favorable assumptions, including lifelong protection against 70% of all cervical cancers and no side effects, vaccination against the human papillomavirus (HPV) is not cost-effective in the Netherlands, according to a study published online July 1 in the Journal of the National Cancer Institute.